SLI
2.019,59
PKT
+11,20
PKT
+0,56
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
24.04.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
24.04.17 | Zurich Insurance Equal-Weight | Morgan Stanley | |
24.04.17 | Holcim market-perform | Bernstein Research | |
24.04.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
24.04.17 | Holcim Neutral | UBS AG | |
24.04.17 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
24.04.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
21.04.17 | Nestlé buy | Deutsche Bank AG | |
21.04.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
21.04.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
21.04.17 | Novartis Neutral | UBS AG | |
21.04.17 | Nestlé buy | UBS AG | |
21.04.17 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
21.04.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
21.04.17 | Nestlé buy | Goldman Sachs Group Inc. | |
21.04.17 | Nestlé overweight | JP Morgan Chase & Co. | |
21.04.17 | Holcim Neutral | JP Morgan Chase & Co. | |
21.04.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
21.04.17 | Nestlé buy | Baader Bank | |
21.04.17 | ABB (Asea Brown Boveri) Hold | S&P Capital IQ | |
20.04.17 | Swiss Re Hold | Deutsche Bank AG | |
20.04.17 | UBS overweight | Morgan Stanley | |
20.04.17 | UBS overweight | Morgan Stanley | |
20.04.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
20.04.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
20.04.17 | Nestlé buy | UBS AG | |
20.04.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
20.04.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
20.04.17 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
20.04.17 | Roche buy | Jefferies & Company Inc. | |
19.04.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
19.04.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
19.04.17 | Novartis Underweight | Morgan Stanley | |
19.04.17 | Nestlé buy | UBS AG | |
18.04.17 | Givaudan buy | Baader Bank | |
18.04.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
18.04.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
18.04.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
18.04.17 | Novartis Neutral | JP Morgan Chase & Co. | |
18.04.17 | Roche overweight | JP Morgan Chase & Co. |